title: Neuroimmune pharmacology of neurodegenerative and mental diseases.
abstract: Neuroimmune pharmacology is a newly emerging field that intersects with neuroscience, immunology, and pharmacology and that is seeking avenues for translational research and better understanding of disease mechanisms. It focuses on the immunity of the central nervous system (CNS) which is greatly influenced by endogenous effectors, such as cytokines and neurotransmitters, and by exogenous substances, including therapeutic compounds, infectious pathogens, and drugs of abuse. In this article, we attempt to raise awareness of the pivotal discovery of how those mediators affect the immunity of the CNS in both physiological conditions and processes of certain mental illnesses, including psychiatric disorders, neurodegenerative diseases, and cerebral dysfunctions due to drugs of abuse. The abnormality in cytokine networks, neurotransmitter homeostasis, and other immune responses may be involved in the neuropathology associated with those mental illnesses, and the therapeutic effects of the potential treatments can be attributed, at least partially, to their immunomodulatory activities. However, the resulting inflammatory cytokines from certain treatments frequently cause psychiatric complications. In addition, the poor neuropathological outcomes frequently found among drug abusers with HIV-1 infection appear to be related to the neurotoxic and immunomodulatory effects of the drugs used. Importantly, glial cells, especially microglia and astrocytes, are key players in the immunomodulatory activities in the CNS, and the functioning CNS is largely dependent upon the reciprocal interactions between neurons and glial cells. Therefore, glia-neuron interactions have become a critical issue for further understanding the disease mechanism. From this review, readers will gain insights into the new field of neuroimmune pharmacology, with a focus on the impacts of CNS immunity on the mental illnesses.
authors.affiliation: Division of Mental Health and Addiction Medicine, Institute of Population Health Sciences, Zhunan, Miaoli County, Taiwan, Republic of China.
authors.forename: Feng-Shiun
authors.initials: FS
authors.lastname: Shie
authors.forename: Yun-Hsiang
authors.initials: YH
authors.lastname: Chen
authors.forename: Chia-Hsiang
authors.initials: CH
authors.lastname: Chen
authors.forename: Ing-Kang
authors.initials: IK
authors.lastname: Ho
mesh_terms: D001921:Brain / Q000276:immunology*; D016207:Cytokines / Q000276:immunology*; D006801:Humans; D001523:Mental Disorders / Q000276:immunology*; D019636:Neurodegenerative Diseases / Q000276:immunology*; D015213:Neuroimmunomodulation / Q000502:physiology*
chemical_list: D016207:Cytokines
references.citation: Int J Neurosci. 2001;111(1-2):11-9
references.pmid: 11913333
references.citation: FASEB J. 2003 Oct;17(13):1954-6
references.pmid: 12897068
references.citation: Ann Neurol. 2000 Feb;47(2):186-94
references.pmid: 10665489
references.citation: J Biol Chem. 2005 Jun 3;280(22):21453-62
references.pmid: 15817469
references.citation: Antiviral Res. 2009 May;82(2):A99-109
references.pmid: 19176219
references.citation: J Neurosci Res. 2005 Dec 15;82(6):831-8
references.pmid: 16273545
references.citation: J Med Chem. 2002 Mar 14;45(6):1292-9
references.pmid: 11881998
references.citation: J Neurochem. 2000 Feb;74(2):457-71
references.pmid: 10646496
references.citation: Int J Dev Neurosci. 1995 Jun-Jul;13(3-4):253-64
references.pmid: 7572279
references.citation: Virology. 2006 Oct 10;354(1):192-206
references.pmid: 16876224
references.citation: Br J Dermatol. 2007 Dec;157(6):1275-7
references.pmid: 17916204
references.citation: J Neurovirol. 1998 Dec;4(6):619-26
references.pmid: 10065903
references.citation: Biol Psychiatry. 2008 Apr 15;63(8):801-8
references.pmid: 18005941
references.citation: Perspect Psychiatr Care. 2008 Oct;44(4):285-9
references.pmid: 18826467
references.citation: Eur J Pharmacol. 1999 May 7;372(1):65-73
references.pmid: 10374716
references.citation: J Investig Med. 2009 Aug;57(6):703-8
references.pmid: 19240648
references.citation: Science. 2005 Jul 15;309(5733):392-3
references.pmid: 16020721
references.citation: Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7162-6
references.pmid: 7638161
references.citation: J Clin Psychopharmacol. 1996 Oct;16(5):403-9
references.pmid: 8889915
references.citation: Neurology. 1993 Nov;43(11):2245-52
references.pmid: 8232937
references.citation: Neurotoxicology. 2006 Mar;27(2):217-28
references.pmid: 16386305
references.citation: Neurochem Int. 2006 May-Jun;48(6-7):416-25
references.pmid: 16500003
references.citation: Front Biosci. 2004 Sep 01;9:2680-5
references.pmid: 15358591
references.citation: J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):241-9
references.pmid: 19194320
references.citation: J Alzheimers Dis. 2004 Dec;6(6 Suppl):S61-74
references.pmid: 15665416
references.citation: J Biol Chem. 2003 Aug 1;278(31):28736-42
references.pmid: 12771134
references.citation: J Immunol. 2000 Jan 1;164(1):361-70
references.pmid: 10605031
references.citation: J Gen Virol. 2008 Jan;89(Pt 1):1-47
references.pmid: 18089727
references.citation: Brain Res Bull. 2001 Mar 1;54(4):329-38
references.pmid: 11306183
references.citation: AIDS. 2007 Sep 12;21(14):1877-86
references.pmid: 17721095
references.citation: Cell. 2010 Mar 19;140(6):918-34
references.pmid: 20303880
references.citation: AIDS. 2006 Sep 11;20(14):1885-8
references.pmid: 16954730
references.citation: Br J Dermatol. 2008 Sep;159(3):704-10
references.pmid: 18627375
references.citation: Neurology. 2007 Oct 30;69(18):1789-99
references.pmid: 17914061
references.citation: Biol Psychiatry. 1988 Feb 15;23(4):326-34
references.pmid: 3422573
references.citation: Neurochem Res. 2003 Feb;28(2):347-52
references.pmid: 12608708
references.citation: Sleep Med Rev. 2005 Oct;9(5):355-64
references.pmid: 16102986
references.citation: J Neurochem. 2010 May;113(3):692-703
references.pmid: 20132465
references.citation: Int Rev Neurobiol. 2002;52:275-302
references.pmid: 12498108
references.citation: Hum Psychopharmacol. 2004 Aug;19(6):397-403
references.pmid: 15303243
references.citation: Clin Cancer Res. 2002 Aug;8(8):2480-7
references.pmid: 12171873
references.citation: Nanomedicine (Lond). 2009 Jul;4(5):557-74
references.pmid: 19572821
references.citation: Curr HIV Res. 2006 Jul;4(3):267-78
references.pmid: 16842080
references.citation: Immunol Cell Biol. 2001 Aug;79(4):350-7
references.pmid: 11488982
references.citation: J Affect Disord. 1998 Jun;49(3):211-9
references.pmid: 9629951
references.citation: J Pharmacol Sci. 2004 Mar;94(3):325-8
references.pmid: 15037818
references.citation: Science. 1983 Jan 21;219(4582):316-8
references.pmid: 6849138
references.citation: Schizophr Res. 2007 Feb;90(1-3):179-85
references.pmid: 17208413
references.citation: Neuropsychopharmacology. 2000 Jul;23(1):89-98
references.pmid: 10869889
references.citation: Depress Anxiety. 2009;26(7):607-11
references.pmid: 19496103
references.citation: Biochem Biophys Res Commun. 2008 Oct 24;375(3):446-9
references.pmid: 18715543
references.citation: Brain Res. 2007 Dec;1186:12-20
references.pmid: 17996850
references.citation: CNS Drugs. 2009;23(4):293-307
references.pmid: 19374459
references.citation: Brain Behav Immun. 1995 Dec;9(4):253-75
references.pmid: 8903845
references.citation: Int Immunopharmacol. 2003 Aug;3(8):1235-46
references.pmid: 12860179
references.citation: Curr Med Res Opin. 2003;19(5):402-10
references.pmid: 13678477
references.citation: Folia Neuropathol. 2005;43(4):311-21
references.pmid: 16416395
references.citation: J Addict Dis. 1994;13(2):1-8
references.pmid: 8204671
references.citation: Schizophr Res. 2002 Apr 1;54(3):281-91
references.pmid: 11950553
references.citation: Nat Med. 2005 May;11(5):545-50
references.pmid: 15834426
references.citation: Psychiatry Res. 1997 Jun 16;71(1):11-7
references.pmid: 9247977
references.citation: J Neurosci. 2005 Mar 16;25(11):2952-64
references.pmid: 15772355
references.citation: J Immunol. 1993 Aug 1;151(3):1175-83
references.pmid: 8393041
references.citation: J Neuroimmune Pharmacol. 2009 Mar;4(1):129-39
references.pmid: 18958626
references.citation: Psychiatry Res. 2008 Sep 30;160(3):256-62
references.pmid: 18722671
references.citation: Int Immunopharmacol. 2008 Apr;8(4):526-33
references.pmid: 18328443
references.citation: Pharmacol Rev. 2008 Jun;60(2):196-209
references.pmid: 18560012
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 1995 Jan;19(1):11-38
references.pmid: 7708925
references.citation: FEMS Immunol Med Microbiol. 2006 Aug;47(3):330-42
references.pmid: 16872369
references.citation: Mol Psychiatry. 2006 Jul;11(7):680-4
references.pmid: 16491133
references.citation: Nature. 1996 Oct 31;383(6603):787-93
references.pmid: 8893001
references.citation: Brain. 2005 Jun;128(Pt 6):1442-53
references.pmid: 15817521
references.citation: N Engl J Med. 2001 Nov 22;345(21):1515-21
references.pmid: 11794217
references.citation: Nat Rev Neurosci. 2007 Jan;8(1):57-69
references.pmid: 17180163
references.citation: Mol Psychiatry. 2005 Jan;10(1):79-104
references.pmid: 15289815
references.citation: Clin Microbiol Rev. 2003 Apr;16(2):209-19
references.pmid: 12692094
references.citation: Acta Psychiatr Scand. 1994 May;89(5):346-51
references.pmid: 8067274
references.citation: J Neuroimmune Pharmacol. 2006 Sep;1(3):280-95
references.pmid: 18040805
references.citation: Lancet. 1996 Aug 10;348(9024):348-9
references.pmid: 8709727
references.citation: Schizophr Res. 1997 Aug 29;26(2-3):221-5
references.pmid: 9323354
references.citation: J Neuroimmune Pharmacol. 2009 Dec;4(4):430-47
references.pmid: 19768553
references.citation: Ann N Y Acad Sci. 2000;917:456-67
references.pmid: 11268373
references.citation: Handb Exp Pharmacol. 2005;(168):385-423
references.pmid: 16596782
references.citation: Int Rev Psychiatry. 2008 Feb;20(1):33-47
references.pmid: 18240061
references.citation: J Neurochem. 2006 Nov;99(3):689-707
references.pmid: 17076654
references.citation: Brain Behav Immun. 2001 Dec;15(4):319-39
references.pmid: 11782102
references.citation: Int Rev Psychiatry. 2008 Feb;20(1):15-24
references.pmid: 18240059
references.citation: Psychosom Med. 2001 May-Jun;63(3):376-86
references.pmid: 11382265
references.citation: J Clin Psychiatry. 2004 Jul;65(7):940-7
references.pmid: 15291683
references.citation: J Neurosci. 2002 Mar 15;22(6):2246-54
references.pmid: 11896164
references.citation: J Neuroimmune Pharmacol. 2006 Mar;1(1):77-89
references.pmid: 18040793
references.citation: Brain Behav Immun. 2009 Feb;23(2):149-58
references.pmid: 18793712
references.citation: Alzheimer Dis Assoc Disord. 1998;12 Suppl 2:S1-6
references.pmid: 9769023
references.citation: Neurology. 1996 Aug;47(2):425-32
references.pmid: 8757015
references.citation: Lancet. 2006 Jan 7;367(9504):29-35
references.pmid: 16399150
references.citation: Immunopharmacology. 1996 Aug;34(1):27-37
references.pmid: 8880223
references.citation: Front Biosci. 2008 May 01;13:3913-8
references.pmid: 18508485
references.citation: Neuropsychol Rev. 2009 Jun;19(2):169-85
references.pmid: 19424802
references.citation: J Leukoc Biol. 1998 Jan;63(1):101-7
references.pmid: 9469479
references.citation: Physiol Rev. 2001 Apr;81(2):741-66
references.pmid: 11274343
references.citation: Psychiatry Res. 1986 Jan;17(1):41-7
references.pmid: 2935897
references.citation: Cell. 1998 Apr 17;93(2):229-40
references.pmid: 9568715
references.citation: Alcohol Health Res World. 1997;21(1):30-41
references.pmid: 15706761
references.citation: J Int Neuropsychol Soc. 2004 Jan;10(1):1-14
references.pmid: 14751002
references.citation: Eur Neuropsychopharmacol. 2007 Dec;17(12):774-80
references.pmid: 17499975
references.citation: Arthritis Rheum. 2010 Mar;62(3):683-93
references.pmid: 20131240
references.citation: Am J Psychiatry. 2000 May;157(5):683-94
references.pmid: 10784457
references.citation: Life Sci. 1999;65(17):1773-86
references.pmid: 10576557
references.citation: Am J Psychiatry. 1997 Dec;154(12):1763-5
references.pmid: 9396961
references.citation: J Psychiatr Res. 2007 Jan-Feb;41(1-2):3-7
references.pmid: 16434055
references.citation: Arch Gen Psychiatry. 1983 Apr;40(4):405-6
references.pmid: 6838321
references.citation: JAMA. 2005 Apr 27;293(16):2003-11
references.pmid: 15855434
references.citation: Neurosci Lett. 2007 Apr 6;416(1):87-91
references.pmid: 17317005
references.citation: Int J Neuropsychopharmacol. 2002 Dec;5(4):401-12
references.pmid: 12466038
references.citation: Neurology. 2006 Oct 24;67(8):1486-9
references.pmid: 17060582
references.citation: J Neurochem. 2004 Dec;91(5):1199-210
references.pmid: 15569263
references.citation: Medicine (Baltimore). 1987 Nov;66(6):407-37
references.pmid: 3316921
references.citation: Nat Rev Neurosci. 2007 Dec;8(12):935-47
references.pmid: 17987031
references.citation: J Neurochem. 2010 Mar;112(6):1415-30
references.pmid: 20050972
references.citation: Neurochem Int. 2004 Sep;45(4):521-7
references.pmid: 15186918
references.citation: J Immunol. 1997 Sep 15;159(6):2994-9
references.pmid: 9300724
references.citation: J Immunol. 2009 Jul 1;183(1):661-9
references.pmid: 19535632
references.citation: Neuropsychopharmacology. 2008 Aug;33(9):2228-36
references.pmid: 17971830
references.citation: Expert Opin Investig Drugs. 2004 Aug;13(8):1033-44
references.pmid: 15268640
references.citation: Neurobiol Aging. 2007 May;28(5):639-47
references.pmid: 16697488
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jan;26(1):33-9
references.pmid: 11853116
references.citation: J Affect Disord. 2004 Oct 15;82(2):175-90
references.pmid: 15488246
references.citation: Int Immunopharmacol. 2006 Apr;6(4):666-71
references.pmid: 16504930
references.citation: Schizophr Res. 1999 May 4;37(1):97-106
references.pmid: 10227112
references.citation: Eur J Pharmacol. 2007 Apr 30;561(1-3):54-62
references.pmid: 17303117
references.citation: Biochem Pharmacol. 2004 Sep 15;68(6):1255-67
references.pmid: 15313424
references.citation: Neurochem Int. 2010 Nov;57(4):440-5
references.pmid: 20193723
references.citation: Int Rev Psychiatry. 2008 Feb;20(1):25-31
references.pmid: 18240060
references.citation: Curr Med Chem. 2007;14(27):2865-71
references.pmid: 18045132
references.citation: Nature. 1999 Jul 22;400(6742):378-82
references.pmid: 10432118
references.citation: J Neuroimmunol. 1993 Jun;45(1-2):137-45
references.pmid: 8392517
references.citation: Psychoneuroendocrinology. 2001 Nov;26(8):797-808
references.pmid: 11585680
references.citation: Brain Res Bull. 1991 Sep-Oct;27(3-4):309-13
references.pmid: 1959024
references.citation: Int J Neuropsychopharmacol. 2009 May;12(4):561-78
references.pmid: 19224657
references.citation: N Engl J Med. 1994 Jun 30;330(26):1880-6
references.pmid: 7832832
references.citation: Neurochem Int. 2009 Jul-Aug;55(1-3):151-6
references.pmid: 19428820
references.citation: J Neurochem. 1991 Jun;56(6):2007-17
references.pmid: 1827495
references.citation: Front Behav Neurosci. 2009 Aug 24;3:14
references.pmid: 19738918
references.citation: Clin Infect Dis. 2004 Mar 15;38(6):890-4
references.pmid: 14999636
references.citation: Ann Rheum Dis. 1999 Sep;58(9):585-7
references.pmid: 10460194
references.citation: Annu Rev Physiol. 2010;72:335-55
references.pmid: 20148679
references.citation: Arch Neurol. 2008 Jan;65(1):65-70
references.pmid: 18195140
references.citation: Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15983-8
references.pmid: 14668448
references.citation: Br J Haematol. 2002 Dec;119(4):1090-7
references.pmid: 12472593
references.citation: Life Sci. 1994;54(21):1579-84
references.pmid: 7910931
references.citation: Neuron. 2009 Oct 15;64(1):133-45
references.pmid: 19840555
references.citation: Glia. 2001 Jul;35(1):72-9
references.pmid: 11424194
references.citation: J Neurosci. 2007 Mar 21;27(12):3057-63
references.pmid: 17376966
references.citation: Brain Pathol. 2002 Oct;12(4):442-55
references.pmid: 12408230
references.citation: Science. 2005 May 27;308(5726):1314-8
references.pmid: 15831717
references.citation: Exp Biol Med (Maywood). 2008 Sep;233(9):1149-60
references.pmid: 18535159
references.citation: Schizophr Res. 2000 Jun 16;43(2-3):164-6
references.pmid: 11001592
references.citation: J Psychiatry Neurosci. 2004 Jan;29(1):11-7
references.pmid: 14719046
references.citation: Immunology. 1997 Jul;91(3):361-8
references.pmid: 9301524
references.citation: Inflamm Res. 1996 Mar;45(3):141-4
references.pmid: 8689394
references.citation: Brain Behav Immun. 2006 Nov;20(6):532-45
references.pmid: 16580814
references.citation: Curr Opin Neurol. 1997 Aug;10(4):319-25
references.pmid: 9266156
references.citation: J Neurosci. 1989 Jun;9(6):2066-72
references.pmid: 2723766
references.citation: Neurology. 2006 Mar 28;66(6):919-21
references.pmid: 16510768
references.citation: IEEE Trans Nanobioscience. 2007 Dec;6(4):262-9
references.pmid: 18217618
references.citation: Ann Pharmacother. 2001 Apr;35(4):489-95
references.pmid: 11302414
references.citation: J Biol Chem. 2005 Feb 18;280(7):5892-901
references.pmid: 15590663
references.citation: Schizophr Res. 2000 Sep 1;44(3):165-75
references.pmid: 10962218
references.citation: Pharm World Sci. 2005 Dec;27(6):423-31
references.pmid: 16341948
references.citation: Am J Psychiatry. 2002 Jun;159(6):1029-34
references.pmid: 12042193